IL1A rs1800546: What Your Genotype Means
The rs1800546 variant is a single nucleotide polymorphism located in the promoter region of the IL1A gene. It is associated with variations in the expression of interleukin-1 alpha, a protein involved in the body's inflammatory response.
What each genotype means
Baseline inflammatory potential
This genotype represents the most common version of the IL1A promoter region. Research suggests this version is associated with standard levels of interleukin-1 alpha expression, though individual inflammatory responses are complex and influenced by many other genetic and environmental factors.
This is the most common genotype in most populations, carried by the majority of individuals of European ancestry.
Intermediate inflammatory potential
Carrying one copy of the T allele may be associated with altered regulation of interleukin-1 alpha expression compared to the CC genotype. While some studies link this variant to a heightened susceptibility to chronic inflammatory conditions, the evidence remains limited and inconsistent across different populations.
This genotype is found in approximately 35-45% of individuals of European ancestry.
Enhanced inflammatory potential
This genotype is associated with the potential for enhanced interleukin-1 alpha expression in certain tissues. Research has explored its link to a heightened susceptibility to various chronic inflammatory diseases, though these associations are often context-dependent and not definitive for any individual.
This genotype is the least common, typically found in roughly 5-10% of individuals of European ancestry.
Understanding the rs1800546 Variant
The rs1800546 variant, often referred to in scientific literature as the -889 C>T polymorphism, is a change in a single DNA building block located in the regulatory region of the IL1A gene. This region, known as the promoter, acts as a control switch that determines how much of a specific protein is produced by the cell. Because this variant sits in a regulatory area rather than the protein-coding sequence itself, it does not change the structure of the interleukin-1 alpha protein. Instead, it is thought to influence the efficiency with which the gene is turned on or off. Researchers study this site because even subtle changes in the regulation of inflammatory proteins can potentially alter how an individual's immune system responds to triggers, making it a subject of interest in the study of chronic inflammatory conditions.
The Role of the IL1A Gene
The IL1A gene provides instructions for making a protein called interleukin-1 alpha. This protein belongs to a family of cytokines, which are signaling molecules that act as messengers within the immune system. Interleukin-1 alpha plays a critical role in initiating and regulating the inflammatory response, which is the body's natural defense against infection and injury. Under normal conditions, this protein helps coordinate the activity of various immune cells to clear pathogens or repair damaged tissue. However, because it is a potent mediator of inflammation, its production must be tightly controlled. When the regulation of this gene is disrupted, it may lead to an overactive or prolonged inflammatory state, which is why researchers investigate how genetic variations in this region might contribute to susceptibility to various inflammatory and autoimmune disorders.
Research and Evidence Strength
Scientific research into rs1800546 has explored its potential links to a variety of conditions, including rheumatoid arthritis, periodontal disease, and other inflammatory disorders. While some studies have suggested that the T allele may be associated with altered levels of interleukin-1 alpha expression and increased risk for certain inflammatory conditions, the evidence remains limited and sometimes inconsistent across different populations. It is important to note that genetic associations are complex; having a specific genotype does not mean an individual will develop a disease. Many factors, including environmental triggers, lifestyle, and the interaction of multiple other genes, play a significant role in health outcomes. Current research continues to investigate these links, but the clinical utility of this variant as a standalone diagnostic or prognostic tool is not established. Findings should be viewed as part of a broader, ongoing scientific inquiry into the genetics of inflammation.
Population Frequency
The distribution of the rs1800546 variant varies across different ancestral groups. In populations of European ancestry, the minor T allele is observed with a frequency typically ranging between 0.25 and 0.30. This means that a significant portion of the population carries at least one copy of this allele. Because allele frequencies can differ substantially between global populations, it is essential to consider ancestry when interpreting genetic data. Researchers use large-scale databases like gnomAD to track these frequencies, which helps in understanding the evolutionary history and potential health implications of specific variants across diverse human groups. Understanding these frequencies is a fundamental step in genomic research, providing context for how common or rare a specific genetic change is within the human population.
Interpreting Your Genetic Information
If you have access to your genetic data regarding the rs1800546 variant, it is important to approach this information with a clear understanding of its limitations. This variant is a subject of scientific research, not a definitive medical test. The presence of a specific genotype does not provide a diagnosis or a prediction of future health. Genetic predispositions are only one piece of a much larger puzzle that includes your overall health history, lifestyle, and environment. You cannot use this information to make medical decisions or change treatments on your own. If you have concerns about your health or family history of inflammatory conditions, the most appropriate step is to consult with a qualified healthcare professional or a genetic counselor. They can help you interpret your results in the context of your personal health and provide guidance based on established clinical standards.
How common is this variant?
The minor T allele frequency is approximately 0.25-0.30 in European ancestry groups, making the CT and TT genotypes relatively common in these populations.
Frequently asked questions
Is rs1800546 a diagnostic test for arthritis?
No, rs1800546 is not a diagnostic test. While it has been studied in the context of inflammatory conditions like arthritis, it is only one of many factors that influence disease risk and cannot be used to diagnose any medical condition.
What does the IL1A gene do?
The IL1A gene provides instructions for making interleukin-1 alpha, a protein that acts as a signaling molecule to help regulate the body's immune and inflammatory responses.
Should I be worried if I have the TT genotype?
No, you should not be worried. Genetic variants are common, and having a specific genotype does not mean you will develop a disease. Many factors contribute to health, and this variant is only a small part of your overall genetic profile.
Can I use this information to change my medication?
No. You should never change your medication or treatment plan based on genetic information without first consulting your doctor or pharmacist. Always discuss your genetic results with a healthcare professional.
Sources & further reading
Educational information only, last refreshed 9/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800546?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29